Prelude Capital Management’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,358
| Closed | -$29.2K | – | 1004 |
|
|
2023
Q2 | $29.2K | Sell |
1,358
-5,210
| -79% | -$112K | ﹤0.01% | 880 |
|
|
2023
Q1 | $185K | Buy |
6,568
+3,289
| +100% | +$92.4K | 0.01% | 784 |
|
|
2022
Q4 | $73.8K | Sell |
3,279
-8,863
| -73% | -$199K | ﹤0.01% | 966 |
|
|
2022
Q3 | $290K | Buy |
12,142
+6,442
| +113% | +$154K | 0.01% | 864 |
|
|
2022
Q2 | $166K | Buy |
+5,700
| New | +$166K | ﹤0.01% | 1127 |
|
|
2022
Q1 | – | Sell |
-1,250
| Closed | -$119K | – | 1540 |
|
|
2021
Q4 | $119K | Hold |
1,250
| – | – | ﹤0.01% | 1320 |
|
|
2021
Q3 | $224K | Sell |
1,250
-66
| -5% | -$11.8K | 0.01% | 979 |
|
|
2021
Q2 | $388K | Buy |
1,316
+66
| +5% | +$19.5K | 0.01% | 865 |
|
|
2021
Q1 | $337K | Buy |
1,250
+190
| +18% | +$51.2K | 0.01% | 741 |
|
|
2020
Q4 | $245K | Sell |
1,060
-176
| -14% | -$40.7K | 0.01% | 592 |
|
|
2020
Q3 | $310K | Buy |
+1,236
| New | +$310K | 0.02% | 379 |
|